Iter Investments
VC Fund
Fort Lauderdale, United States
Iter Investments is a venture capital firm that seeks to invest in companies operating in the mental health sector. It partners primarily with early-stage private companies operating across the psychedelic ecosystem. They assist entrepreneurs and management teams to build great companies that will transform the mental and behavioral healthindustry.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Iter Investments invests in
Stages Iter Investments invests in
Countries Iter Investments invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 3 (43%)
- Health Care 3 (43%)
- Neuroscience 2 (29%)
- Gaming 1 (14%)
- Sensor 1 (14%)
Stage
- Seed 4 (57%)
- Series A 2 (29%)
- Series C 1 (14%)
Country
- United States 5 (71%)
- Canada 2 (29%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dustin Robinson
Founder and Managing Principal
|
Founder and Managing Principal | Total investments: 2 | Find email | |
Roberto Velarde
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sensorium Therapeutics
|
Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines. Founded in 2021, the company is based in Boston, Massachusetts. | $30M / Series A / Oct 04, 2022 | |
Beckley Retreats
|
Beckley Retreats is a provider of virtual integration programs for healing. The company focuses on helping people with neurological and psychiatric disorders and offer training and certification for practitioners. Beckley Retreats offers a safe location, holistic training, dedicated care, and access to medical care. | $1.5M / Seed / Oct 03, 2022 | |
Muse
|
Muse has developed brainwave-controlled computing technology and applications that converts brainwaves into digital signals. They have created a hardware and software platform technology that converts brainwaves into digital signals that are fed into a computer. InteraXon then provides consumers with applications that use these brainwaves toperform activities such as meditation, gaming, ADHD assistance, and many others to come.The company was founded in 2007 and is headquartered in Toronto, Ontario. | $9.5M / Series C / Aug 11, 2022 | |
Fluence
|
Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy. Our programs are designed for licensed professionals and advanced graduate students who have an opportunity to work with patient populations. Although none of our courses have specific prerequisites, a basic working knowledge ofthe mental health field and practice of psychotherapy is helpful. Our programs are interactive; we engage in discussion, demonstration, self-reflection exercises, and role plays. Some of our classes and programs are reserved for licensed clinicians, but many are open to anyone who wishes to attend. | $1.4M / Seed / Feb 15, 2022 | |
Quantified Citizen
|
Quantified Citizen makes scientific research accessible by modernizing the process. We empower citizen scientists and professional researchers to easily participate and create their own scientific studies, building a movement towards more timely insights into the latest health research. | $1.6M / Seed / Aug 20, 2021 | |
Psilera
|
Psilera develops therapies aimed at neurological and psychiatric disorders by leveraging neuroplastogens, compounds that promote brain plasticity without hallucinogenic effects. The company builds a proprietary library of serotonergic compounds and applies computational tools to design molecules for conditions such as alcohol use disorder andfrontotemporal dementia. Its research pipeline emphasizes non-hallucinogenic derivatives of psychedelic compounds to provide safe and scalable treatment options. Psilera integrates medicinal chemistry, neuroscience, and pharmacology to create small-molecule drugs that address unmet medical needs. Through this approach, the company seeks to expand treatment possibilities for patients facing hard-to-treat neurological conditions. | $2.5M / Seed / Jul 01, 2021 | |
TRIPP
|
TRIPP: Empowering You To Change The Way You FeelNamed the Best VR Meditation App of 2020 by Men’s Health and VR Fitness Insider, The Washington Post calls TRIPP “Meditation-meets-a-video-game-meets-a-Happy-Pill!”TRIPP is the award-winning XR platform designed to address mental and emotional well-being. Proven to drive deep engagement, TRIPPcreates advanced digital products that are based on scientific research and delivered through virtual reality, augmented reality, and mobile devices. TRIPP's platform is currently delivering wellness solutions into consumer households, Fortune 1000 companies and hospitals/clinics worldwide. | $11M / Series A / Jun 25, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Iter Investments invest in?
Iter Investments invests primarily in Medical, Health Care and Neuroscience startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Iter Investments?
Public channels for Iter Investments include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Iter Investments?
The team at Iter Investments includes Dustin Robinson (Founder and Managing Principal) and Roberto Velarde (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
